Skip to main content
Premium Trial:

Request an Annual Quote

Yourgene Health to Provide Back-to-Work COVID-19 Testing Under UK Partnership

NEW YORK – Yourgene Health said on Tuesday that it has partnered with international payments firm Caxton and immunity passport app provider Hooha Innovations to provide back-to-work molecular COVID-19 testing for businesses in the UK.

Under the collaboration, Caxton will offer COVID-19 tests to its network of corporate clients and their employees, who can request a test using Hooha's immunity passport app Prova. Yourgene will provide sample collection kits, train healthcare professionals to take samples, and conduct the testing in its Manchester laboratory using its CE-marked, PCR-based Clarigene SARS-CoV-2 assay. Individuals will obtain their test results through the Prova app, which allows them to share them without revealing any personal information.

Yourgene said it is still on track to release a research-use-only version of the Clarigene test by the end of June and to obtain CE marking for an in vitro diagnostic kit version in July, as announced in May.

"We are proud to support this effort as the COVID-19 lab partner to this collaboration, working with  Caxton and Prova, enabling  employees  to  return to  work safely," said Yourgene CEO Lyn Rees in a statement. "We look forward to updating the market as the project progresses as we expect to launch in summer 2020."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.